344 related articles for article (PubMed ID: 26091388)
1. Topical Calcipotriol Therapy for Mild-to-Moderate Alopecia Areata: A Retrospective Study.
Çerman AA; Solak SS; Altunay İ; Küçükünal NA
J Drugs Dermatol; 2015 Jun; 14(6):616-20. PubMed ID: 26091388
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of topical calcipotriol in management of alopecia areata: A pilot study.
Narang T; Daroach M; Kumaran MS
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133875
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
Tosti A; Iorizzo M; Botta GL; Milani M
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
[TBL] [Abstract][Full Text] [Related]
4. Topical calcipotriol vs narrowband ultraviolet B in treatment of alopecia areata: a randomized-controlled trial.
El Taieb MA; Hegazy EM; Ibrahim HM; Osman AB; Abualhamd M
Arch Dermatol Res; 2019 Oct; 311(8):629-636. PubMed ID: 31236672
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial.
Mancuso G; Balducci A; Casadio C; Farina P; Staffa M; Valenti L; Milani M
Int J Dermatol; 2003 Jul; 42(7):572-5. PubMed ID: 12839615
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series.
Nasimi M; Ghandi N; Abedini R; Mirshamsi A; Shakoei S; Seirafi H
Arch Dermatol Res; 2019 Oct; 311(8):607-613. PubMed ID: 31165933
[TBL] [Abstract][Full Text] [Related]
7. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE
Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).
Kwon O; Senna MM; Sinclair R; Ito T; Dutronc Y; Lin CY; Yu G; Chiasserini C; McCollam J; Wu WS; King B
Am J Clin Dermatol; 2023 May; 24(3):443-451. PubMed ID: 36855020
[TBL] [Abstract][Full Text] [Related]
9. Higher concentrations of dithranol appear to induce hair growth even in severe alopecia areata.
Ngwanya MR; Gray NA; Gumedze F; Ndyenga A; Khumalo NP
Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28598005
[TBL] [Abstract][Full Text] [Related]
10. Targeted photochemotherapy in alopecia areata.
Açıkgöz G; Yeşil H; Çalışkan E; Tunca M; Akar A
Photodermatol Photoimmunol Photomed; 2013 Dec; 29(6):318-22. PubMed ID: 24102724
[TBL] [Abstract][Full Text] [Related]
11. Comparison of azelaic acid and anthralin for the therapy of patchy alopecia areata: a pilot study.
Sasmaz S; Arican O
Am J Clin Dermatol; 2005; 6(6):403-6. PubMed ID: 16343028
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors that affect the response to topical treatment in patchy alopecia areata.
Ucak H; Cicek D; Demir B; Erden I; Ozturk S
J Eur Acad Dermatol Venereol; 2014 Jan; 28(1):34-40. PubMed ID: 23181708
[TBL] [Abstract][Full Text] [Related]
13. Use of adapalene in alopecia areata: Efficacy and safety of mometasone furoate 0.1% cream versus combination of mometasone furoate 0.1% cream and adapalene 0.1% gel in alopecia areata.
Unal M
Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29193637
[TBL] [Abstract][Full Text] [Related]
14. Topical immunomodulation with diphenylcyclopropenone for alopecia areata: the Lebanese experience.
El Khoury J; Abd-el-Baki J; Succariah F; Abbas O; Kibbi AG; Kurban M
Int J Dermatol; 2013 Dec; 52(12):1551-6. PubMed ID: 24134785
[TBL] [Abstract][Full Text] [Related]
15. Hair regrowth with topical triiodothyronine ointment in patients with alopecia areata: a double-blind, randomized pilot clinical trial of efficacy.
Nasiri S; Haghpanah V; Taheri E; Heshmat R; Larijani B; Saeedi M
J Eur Acad Dermatol Venereol; 2012 May; 26(5):654-6. PubMed ID: 21521379
[TBL] [Abstract][Full Text] [Related]
16. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.
Olsen EA; Carson SC; Turney EA
Arch Dermatol; 1992 Nov; 128(11):1467-73. PubMed ID: 1444500
[TBL] [Abstract][Full Text] [Related]
17. Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in children: a randomized clinical trial.
Lenane P; Macarthur C; Parkin PC; Krafchik B; DeGroot J; Khambalia A; Pope E
JAMA Dermatol; 2014 Jan; 150(1):47-50. PubMed ID: 24226568
[TBL] [Abstract][Full Text] [Related]
18. Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata.
Tobin DJ; Gardner SH; Lindsey NJ; Hoffmann R; Happle R; Freyschmidt-Paul P
Eur J Dermatol; 2002; 12(4):327-34. PubMed ID: 12095876
[TBL] [Abstract][Full Text] [Related]
19. Could azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata? A pilot study.
Farshi S; Mansouri P; Safar F; Khiabanloo SR
Int J Dermatol; 2010 Oct; 49(10):1188-93. PubMed ID: 20883409
[TBL] [Abstract][Full Text] [Related]
20. A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata.
Mikhaylov D; Pavel A; Yao C; Kimmel G; Nia J; Hashim P; Vekaria AS; Taliercio M; Singer G; Karalekas R; Baum D; Mansouri Y; Lebwohl MG; Guttman-Yassky E
Arch Dermatol Res; 2019 Jan; 311(1):29-36. PubMed ID: 30417279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]